PwC MoneyTree is the go-to source for Venture Capital firms and high-growth startups.
The PwC MoneyTree website is home to the PwC/CB Insights quarterly MoneyTree Report. It contains historical trend data beginning with 1995, updates on the Venture Capital and high-growth startups ecosystem, and relevant insights from PwC’s emerging company services and venture capital tax, audit and advisory professionals. The PwC/CB Insights MoneyTree Report is the definitive source of information on venture capital investments in emerging companies. This study is a staple of the financial community, entrepreneurs, government policymakers and the business press worldwide.
The United States recorded its third consecutive quarter with over 30 mega-round activity of $100M or more, resulting in 45 mega-rounds in Q2’18 and continuing the trend of larger deals. However, mega-rounds declined as a percentage of total VC funding to 34%, the second straight quarterly decline. The overall deal activity among VC-backed companies in the US increased by 9%.
PwC and CB Insights' Healthcare MoneyTree report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.
Deal activity looks to be resurgent with $23B invested in VC-backed startups setting a new quarterly funding high since the start of this century, while also increasing activity to over 1,400 deals. Additionally, 2018's mega-rounds are currently on pace to beat what was an unprecedented 2017 -- which posted 111 mega-rounds.
Partner, US Pharmaceuticals and Life Sciences , PwC US
Tel: +1 (408) 817 5029